Pathological looping in the synucleinopathies: Investigating the link between Parkinson's disease and Gaucher disease

DMM Disease Models and Mechanisms

Volumn 4, Issue 6, 2011, Pages 713-715

  Kinghorn, Kerri J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; PROSAPOSIN; SHORT HAIRPIN RNA; SNARE PROTEIN; SPHINGOMYELIN;

CELL MEMBRANE; DEMENTIA; ENDOPLASMIC RETICULUM; GAUCHER DISEASE; GENETIC RISK; GOLGI COMPLEX; IMMUNOELECTRON MICROSCOPY; LEWY BODY; LIPID METABOLISM; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; NERVE CELL; NERVE DEGENERATION; NEUROBLASTOMA; NEUROTOXICITY; NONHUMAN; NOTE; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING;

ALPHA-SYNUCLEIN; ANIMALS; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; LYSOSOMES; MODELS, BIOLOGICAL; PARKINSON DISEASE;

EID: 81455128254     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.008615     Document Type: Note

References (22)

1. Bembi, B., Zambito Marsala, S., Sidransky, E., Ciana, G., Carrozzi, M., Zorzon, M., Martini, C., Gioulis, M., Pittis, M. G. and Capus, L. (2003). Gaucher's disease with Parkinson's disease: clinical and pathological aspects. Neurology 61, 99-101. (Pubitemid 36818755)
2. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F. et al. (2006). Alpha-synuclein blocks ERGolgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328. (Pubitemid 44480951)
3. Cox, T. M. (2010). Gaucher disease: clinical profile and therapeutic developments. Biologics 4, 299-313.
4. Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T. and Sulzer, D. (2004). Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292-1295. (Pubitemid 39129234)
5. Cullen, V., Sardi, S. P., Ng, J., Xu, Y. H., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I., Saftig, P., Woulfe, J. et al. (2011). Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing. Ann Neurol. 69, 940-953.
6. Farfel-Becker, T., Vitner, E. B. and Futerman, A. H. (2011). Animal models for Gaucher disease research. Dis. Model. Mech. 4, 746-752.
7. Giasson, B. I., Murray, I. V., Trojanowski, J. Q. and Lee, V. M. (2001). A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J. Biol. Chem. 276, 2380-2386.
8. Goker-Alpan, O., Schiffmann, R., LaMarca, M. E., Nussbaum, R. L., McInerney-Leo, A. and Sidransky, E. (2004). Parkinsonism among, Gaucher disease carriers. J. Med. Genet. 41, 937-940.
9. Goker-Alpan, O., Stubblefield, B. K., Giasson, B. I. and Sidransky, E. (2010). Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders. Acta Neuropathol. 120, 641-649.
10. Manning-Bog, A. B., Schüle, B. and Langston, J. W. (2009). Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism. Neurotoxicology 30, 1127-1132.
11. Mazzulli, J. R., Xu, Y. H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A. and Krainc, D. (2011). Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37-52.
12. Neudorfer, O., Giladi, N., Elstein, D., Abrahamov, A., Turezkite, T., Aghai, E., Reches, A., Bembi, B. and Zimran, A. (1996). Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 89, 691-694. (Pubitemid 26319021)
13. Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R. et al. (2009). Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 132, 1783-1794.
14. Sardi, S. P., Clarke, J., Kinnecom, C., Tamsett, T. J., Li, L., Stanek, L. M., Passini, M. A., Grabowski, G. A., Schlossmacher, M. G., Sidman, R. L. et al. (2011). CNS expression of glucocerebrosidase corrects {alpha}-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc. Natl. Acad. Sci. USA 108, 12101-12106.
15. Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A. et al. (2009). Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 361, 1651-1661.
16. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. and Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
17. Tayebi, N., Walker, J., Stubblefield, B., Orvisky, E., LaMarca, M. E., Wong, K., Rosenbaum, H., Schiffmann, R., Bembi, B. and Sidransky, E. (2003). Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol. Genet. Metab. 79, 104-109. (Pubitemid 36693928)
18. Thayanidhi, N., Helm, J. R., Nycz, D. C., Bentley, M., Liang, Y. and Hay, J. C. (2010). Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs. Mol. Biol. Cell 21, 850-863.
19. Vogiatzi, T., Xilouri, M., Vekrellis, K. and Stefanis, L. (2008). Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J. Biol. Chem. 283, 23542-23556.
20. Volles, M. J. and Lansbury, P. T., Jr (2003). Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 42, 7871-7878. (Pubitemid 36807703)
21. Xu, Y. H., Sun, Y., Ran, H., Quinn, B., Witte, D. and Grabowski, G. A. (2011). Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models. Mol. Genet. Metab. 102, 436-447.
22. Yap, T. L., Gruschus, J. M., Velayati, A., Westbroek, W., Goldin, E., Moaven, N., Sidransky, E. and Lee, J. C. (2011). Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases. J. Biol. Chem. 12, 28080-28088.